BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25183715)

  • 1. Reply: biomarkers of 'acute-onset' chronic inflammatory demyelinating polyneuropathy.
    Park SB; Sung JY; Tani J; Kiernan MC; Lin CS
    Brain; 2015 Mar; 138(Pt 3):e336. PubMed ID: 25183715
    [No Abstract]   [Full Text] [Related]  

  • 2. Biomarkers of 'acute-onset' chronic inflammatory demyelinating polyneuropathy.
    Miura Y; Shahrizaila N; Yuki N
    Brain; 2015 Mar; 138(Pt 3):e335. PubMed ID: 25183714
    [No Abstract]   [Full Text] [Related]  

  • 3. Early identification of 'acute-onset' chronic inflammatory demyelinating polyneuropathy.
    Sung JY; Tani J; Park SB; Kiernan MC; Lin CS
    Brain; 2014 Aug; 137(Pt 8):2155-63. PubMed ID: 24983276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comment on acute-onset chronic inflammatory demyelinating polyneuropathy versus fluctuating Guillain-Barré syndrome.
    Galassi G
    Muscle Nerve; 2011 Oct; 44(4):610-2; author reply 612. PubMed ID: 21922476
    [No Abstract]   [Full Text] [Related]  

  • 5. Systemic lupus erythematosus associated relapsing polyneuropathy: recurrent Guillain-Barré syndrome or chronic inflammatory demyelinating polyradiculoneuropathy?
    Zhang H; Wu J
    Muscle Nerve; 2011 Oct; 44(4):609-10; author reply 610. PubMed ID: 21922475
    [No Abstract]   [Full Text] [Related]  

  • 6. Lecture in honour of Professor Emeritus Fritz Buchthal. Acute and chronic demyelinating polyneuropathy: an overview.
    Trojaborg W
    Electroencephalogr Clin Neurophysiol Suppl; 1999; 50():16-27. PubMed ID: 10689443
    [No Abstract]   [Full Text] [Related]  

  • 7. Differences between acute-onset chronic inflammatory demyelinating polyneuropathy and acute inflammatory demyelinating polyneuropathy in adult patients.
    Alessandro L; Pastor Rueda JM; Wilken M; Querol L; Marrodán M; Acosta JN; Rivero A; Barroso F; Farez MF
    J Peripher Nerv Syst; 2018 Sep; 23(3):154-158. PubMed ID: 29603827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with chronic inflammatory demyelinating polyneuropathy initially diagnosed as Guillain-Barré syndrome.
    Odaka M; Yuki N; Hirata K
    J Neurol; 2003 Aug; 250(8):913-6. PubMed ID: 12928908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guillain Barré syndrome and other immune mediated neuropathies: diagnosis and classification.
    Eldar AH; Chapman J
    Autoimmun Rev; 2014; 13(4-5):525-30. PubMed ID: 24434363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronic inflammatory demyelinating polyneuropathy with an acute onset. Clinical case].
    Suponeva NA; Grishina DA; Ryabinkina YV; Arestova AS; Melnik EA; Tumilovich TA
    Ter Arkh; 2022 May; 94(4):544-551. PubMed ID: 36286806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent aspects of acute and chronic inflammatory polyneuropathies: Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy].
    Pascual-Pascual SI
    Rev Neurol; 2002 Aug 1-15; 35(3):269-76. PubMed ID: 12235589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical Clinical Presentations of Pediatric Acute Immune-Mediated Polyneuropathy.
    Yosha-Orpaz N; Aharoni S; Rabie M; Nevo Y
    J Child Neurol; 2019 Apr; 34(5):268-276. PubMed ID: 30674221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inappropriate secretion of antidiuretic hormone in a patient with chronic inflammatory demyelinating polyneuropathy.
    Saito T
    Intern Med; 2005 Jul; 44(7):685-6. PubMed ID: 16093583
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical and electrophysiological parameters distinguishing acute-onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathy.
    Dionne A; Nicolle MW; Hahn AF
    Muscle Nerve; 2010 Feb; 41(2):202-7. PubMed ID: 19882646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired inflammatory demyelinating neuropathies.
    Ensrud ER; Krivickas LS
    Phys Med Rehabil Clin N Am; 2001 May; 12(2):321-34, ix. PubMed ID: 11345010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guillain-Barre or CIDP? That is the question.
    Smith BE
    Neurology; 2010 May; 74(21):1664-5. PubMed ID: 20445150
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy: A "grand cru" of updated data.
    Vallat JM; Mathis S; Magy L
    Eur J Neurol; 2021 Nov; 28(11):3545-3546. PubMed ID: 34152068
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical guideline review: Guillain-barre syndrome and chronic inflammatory demyelinating polyneuropathy].
    Mori K; Hattori N; Sobue G
    Nihon Naika Gakkai Zasshi; 2002 Aug; 91(8):2443-57. PubMed ID: 12373856
    [No Abstract]   [Full Text] [Related]  

  • 19. IL-8 as a potential biomarker in Guillain-Barre Syndrome.
    Breville G; Lascano AM; Roux-Lombard P; Lalive PH
    Eur Cytokine Netw; 2019 Dec; 30(4):130-134. PubMed ID: 32096474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nivolumab-induced chronic inflammatory demyelinating polyradiculoneuropathy mimicking rapid-onset Guillain-Barré syndrome: a case report.
    Tanaka R; Maruyama H; Tomidokoro Y; Yanagiha K; Hirabayashi T; Ishii A; Okune M; Inoue S; Sekine I; Tamaoka A; Fujimoto M
    Jpn J Clin Oncol; 2016 Sep; 46(9):875-8. PubMed ID: 27380808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.